comparemela.com

Latest Breaking News On - Olema pharmaceuticals stock - Page 1 : comparemela.com

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup

Analysts at Citigroup started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a report released on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $20.00 price target on the stock. Citigroup’s price target points to a potential upside of 72.12% from the company’s current price. Separately, HC Wainwright […]

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Given Average Rating of Buy by Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have received an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have covered the stock in […]

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Receives $19 40 Consensus Target Price from Brokerages

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued ratings on the stock in the last year […]

Insider Selling: Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Director Sells $30,200 00 in Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Rating) Director Cyrus Harmon sold 5,000 shares of the firm’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $6.04, for a total value of $30,200.00. Following the sale, the director now owns 1,053,714 shares in the company, valued at approximately […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.